Department of Health and Human Services | ||||||||||||||||||||||||||||||||||||||||||||||
2013 Medical Loss Ratio Reporting Form | ||||||||||||||||||||||||||||||||||||||||||||||
Part 1 - Summary of Data | ||||||||||||||||||||||||||||||||||||||||||||||
Group Affiliation: | Federal EIN : | Federal Tax Exempt | ||||||||||||||||||||||||||||||||||||||||||||
Company Name: | A.M. Best Number: | Issuer ID: | Merge Markets - Ind/SmGrp | |||||||||||||||||||||||||||||||||||||||||||
DBA / Marketing Name: | NAIC Group Code: | Business in the State of: | Not-For-Profit | |||||||||||||||||||||||||||||||||||||||||||
Address: | NAIC Company Code: | Domiciliary State: | MLR Reporting Year: | |||||||||||||||||||||||||||||||||||||||||||
2013 | ||||||||||||||||||||||||||||||||||||||||||||||
Health Insurance Coverage | Mini-Med Plans | Expatriate Plans | Student Health Plans | Government Program Plans | Other Health Business | Aggregate 2% Rule | Uninsured Plans | |||||||||||||||||||||||||||||||||||||||
Individual | Small Group | Large Group | Individual | Small Group | Large Group | Small Group | Large Group | Individual | ||||||||||||||||||||||||||||||||||||||
Part 1 NOTE: REFER TO MLR INSTRUCTIONS, FORMULAS RESOURCE AND TABLES RESOURCE FOR IMPORTANT INFORMATION ABOUT COMPLETING EACH COLUMN AND ROW. |
NAIC Supp. Health Care Exhibit Line | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Total as of 12/31/13 | Total as of 3/31/13 | Dual Contract (Included in 3/31/13) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 3/31/13 | Dual Contract (Included in 3/31/13) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 12/31/13 | Total as of 12/31/13 | Total as of 12/31/13 | ||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | ||||
1. | Premium | |||||||||||||||||||||||||||||||||||||||||||||
1.1 | Total direct premium earned | Pt 1, Ln 1.1 | ||||||||||||||||||||||||||||||||||||||||||||
1.2 | Federal high risk pools | Pt 1, Ln 1.2 | ||||||||||||||||||||||||||||||||||||||||||||
1.3 | State high risk pools | Pt 1, Ln 1.3 | ||||||||||||||||||||||||||||||||||||||||||||
1.4 | Net assumed less ceded reinsurance premium earned (exclude amounts already reported in Line 1.1) | Pt 1, Ln 1.9 | ||||||||||||||||||||||||||||||||||||||||||||
1.5 | Other adjustments due to MLR calculations - premium | Pt 1, Ln 1.10 | ||||||||||||||||||||||||||||||||||||||||||||
1.6 | Risk revenue | Pt 1, Ln 1.11 | ||||||||||||||||||||||||||||||||||||||||||||
2. | Claims | |||||||||||||||||||||||||||||||||||||||||||||
2.1 | Total incurred claims (MLR Form Part 2, Line 2.16) | Pt 1, Ln 5.0 | ||||||||||||||||||||||||||||||||||||||||||||
2.2 | Prescription drugs (informational only; already included in total incurred claims above) |
Pt 1, Ln 2.2 | ||||||||||||||||||||||||||||||||||||||||||||
2.3 | Pharmaceutical rebates (informational only; already excluded from total incurred claims above) |
Pt 1, Ln 2.3 | ||||||||||||||||||||||||||||||||||||||||||||
2.4 | State stop loss, market stabilization and claim/census based assessments (informational only; already excluded from total incurred claims above) |
Pt 1, Ln 2.4 | ||||||||||||||||||||||||||||||||||||||||||||
2.5 | Net assumed less ceded claims incurred (exclude amounts already reported in Line 2.1) | Pt 1, Ln 5.1 | ||||||||||||||||||||||||||||||||||||||||||||
2.6 | Other adjustments due to MLR calculations – claims incurred | Pt 1, Ln 5.2 | ||||||||||||||||||||||||||||||||||||||||||||
2.7 | Rebates paid | Pt 1, Ln 5.3 | ||||||||||||||||||||||||||||||||||||||||||||
2.8 | Estimated rebates unpaid at the end of the previous MLR reporting year | Pt 1, Ln 5.4 | ||||||||||||||||||||||||||||||||||||||||||||
2.9 | Estimated rebates unpaid at the end of the MLR reporting year | Pt 1, Ln 5.5 | ||||||||||||||||||||||||||||||||||||||||||||
2.10 | Fee-for-service and co-pay revenue (net of expenses) | Pt 1, Ln 5.6 | ||||||||||||||||||||||||||||||||||||||||||||
2.11 | Allowable fraud reduction expenses (MLR Form Part 2, Line 2.17) | Pt 1, Ln 4 | ||||||||||||||||||||||||||||||||||||||||||||
3. | Federal and State Taxes and Licensing or Regulatory Fees | |||||||||||||||||||||||||||||||||||||||||||||
3.1 | Federal taxes and assessments incurred by the reporting issuer during the MLR reporting year | Pt 1, Ln 1.5 | ||||||||||||||||||||||||||||||||||||||||||||
3.1 a Federal income taxes deductible from premium in MLR calculations | ||||||||||||||||||||||||||||||||||||||||||||||
3.1 b Patient Centered Outcomes Research Institute (PCORI) Fee | ||||||||||||||||||||||||||||||||||||||||||||||
3.1 c Other Federal Taxes (other than income tax) and assessments deductible from premium | ||||||||||||||||||||||||||||||||||||||||||||||
3.2 | State insurance, premium and other taxes incurred by the reporting issuer during the MLR reporting year (deductible from premium in MLR calculation) | Pt 1, Ln 1.6 | ||||||||||||||||||||||||||||||||||||||||||||
3.2 a State income, excise, business, and other taxes | ||||||||||||||||||||||||||||||||||||||||||||||
3.2 b State premium taxes | ||||||||||||||||||||||||||||||||||||||||||||||
3.2 c Community benefit expenditures deductible from premium in MLR calculations | Pt 1, Ln 1.6a | |||||||||||||||||||||||||||||||||||||||||||||
3.3 | Regulatory authority licenses and fees | Pt 1, Ln 1.7 | ||||||||||||||||||||||||||||||||||||||||||||
4. | Health Care Quality Improvement Expenses Incurred | |||||||||||||||||||||||||||||||||||||||||||||
4.1 | Improve health outcomes | Pt 1, Ln 6.1 | ||||||||||||||||||||||||||||||||||||||||||||
4.2 | Activities to prevent hospital readmission | Pt 1, Ln 6.2 | ||||||||||||||||||||||||||||||||||||||||||||
4.3 | Improve patient safety and reduce medical errors | Pt 1, Ln 6.3 | ||||||||||||||||||||||||||||||||||||||||||||
4.4 | Wellness and health promotion activities | Pt 1, Ln 6.4 | ||||||||||||||||||||||||||||||||||||||||||||
4.5 | Health information technology expenses related to improving health care quality | Pt 1, Ln 6.5 | ||||||||||||||||||||||||||||||||||||||||||||
4.6 | Allowable Implementation ICD-10 expenses (not to exceed 0.3% of premium) | Pt 1, Ln 16a | ||||||||||||||||||||||||||||||||||||||||||||
5. | Non-Claims Costs | |||||||||||||||||||||||||||||||||||||||||||||
5.1 | Cost containment expenses not included in quality improvement expenses in Section 4 | Pt 1, Ln 8.1 | ||||||||||||||||||||||||||||||||||||||||||||
5.2 | All other claims adjustment expenses | Pt 1, Ln 8.2 | ||||||||||||||||||||||||||||||||||||||||||||
5.3 | Direct sales salaries and benefits | Pt 1, Ln 10.1 | ||||||||||||||||||||||||||||||||||||||||||||
5.4 | Agents and brokers fees and commissions | Pt 1, Ln 10.2 | ||||||||||||||||||||||||||||||||||||||||||||
5.5 | Other taxes | |||||||||||||||||||||||||||||||||||||||||||||
5.5a Taxes and assessments (exclude amounts reported in Section 3 or Line 10) |
||||||||||||||||||||||||||||||||||||||||||||||
5.5b Fines and penalties of regulatory authorities (exclude amounts reported in Line 3.3) | ||||||||||||||||||||||||||||||||||||||||||||||
5.6 | Other general and administrative expenses | |||||||||||||||||||||||||||||||||||||||||||||
5.7 | Community benefit expenditures (informational only; include amounts reported in Lines 3.2c and 5.6) | Pt 1, Ln 10.4a | ||||||||||||||||||||||||||||||||||||||||||||
5.8 | ICD-10 implementation expenses (informational only; include amounts reported in Lines 4.6 and 5.6) | Pt 1, Ln 16 | ||||||||||||||||||||||||||||||||||||||||||||
6. | Income from fees of uninsured plans | Pt 1, Ln 12 | ||||||||||||||||||||||||||||||||||||||||||||
7. | Other Indicators or information | |||||||||||||||||||||||||||||||||||||||||||||
7.1 | Number of policies/certificates | Pt 1 Other, Ln 1 | ||||||||||||||||||||||||||||||||||||||||||||
7.2 | Number of covered lives | Pt 1 Other, Ln 2 | ||||||||||||||||||||||||||||||||||||||||||||
7.3 | Number of groups | Pt 1 Other, Ln 3 | ||||||||||||||||||||||||||||||||||||||||||||
7.4 | Member months | Pt 1 Other, Ln 4 | ||||||||||||||||||||||||||||||||||||||||||||
7.5 | Number of life-years | |||||||||||||||||||||||||||||||||||||||||||||
Grand Total as of 12/31/12 for ALL markets in col. 1-43 | ||||||||||||||||||||||||||||||||||||||||||||||
8. | Net investment income and other gain / (loss) | Pt 1, Ln 13 | ||||||||||||||||||||||||||||||||||||||||||||
9. | Other Federal income taxes (exclude taxes on Line 3.1a, 3.1b, and 3.1c) | Pt 1, Ln 14 | ||||||||||||||||||||||||||||||||||||||||||||
Cell Keys: | ||||||||||||||||||||||||||||||||||||||||||||||
Blank cells require input from issuer | ||||||||||||||||||||||||||||||||||||||||||||||
Grey cells require no data input – input will result in an upload failure | ||||||||||||||||||||||||||||||||||||||||||||||
Pink cells require no data input - locked down | ||||||||||||||||||||||||||||||||||||||||||||||
Blue cells require a calculation by the issuer |
Department of Health and Human Services | ||||||||||||||||||||||||||||||||||||||||||||||
2013 Medical Loss Ratio Reporting Form | ||||||||||||||||||||||||||||||||||||||||||||||
Part 2 - Premium and Claims | ||||||||||||||||||||||||||||||||||||||||||||||
Group Affiliation: | Federal EIN : | Federal Tax Exempt | ||||||||||||||||||||||||||||||||||||||||||||
Company Name: | A.M. Best Number: | Issuer ID: | Merge Markets - Ind/SmGrp | |||||||||||||||||||||||||||||||||||||||||||
DBA / Marketing Name: | NAIC Group Code: | Business in the State of: | Not-For-Profit | |||||||||||||||||||||||||||||||||||||||||||
Address: | NAIC Company Code: | Domiciliary State: | MLR Reporting Year: | |||||||||||||||||||||||||||||||||||||||||||
2013 | ||||||||||||||||||||||||||||||||||||||||||||||
Health Insurance Coverage | Mini-Med Plans | Expatriate Plans | Student Health Plans | Government Program Plans | Other Health Business | Aggregate 2% Rule | Uninsured Plans | |||||||||||||||||||||||||||||||||||||||
Individual | Small Group | Large Group | Individual | Small Group | Large Group | Small Group | Large Group | Individual | ||||||||||||||||||||||||||||||||||||||
Part 2 NOTE: REFER TO MLR INSTRUCTIONS, FORMULAS RESOURCE AND TABLES RESOURCE FOR IMPORTANT INFORMATION ABOUT COMPLETING EACH COLUMN AND ROW. |
NAIC Supp. Health Care Exhibit Line | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Total as of 12/31/13 | Total as of 3/31/13 | Dual Contract (Included in 3/31/13) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 3/31/13 | Dual Contract (Included in 3/31/13) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 3/31/14 | Dual Contract (Included in 3/31/14) | Deferred PY1 (Add) | Deferred CY (Subtract) | Total as of 12/31/13 | Total as of 12/31/13 | Total as of 12/31/13 | Total as of 12/31/13 | ||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | ||||
1. | Premium: | |||||||||||||||||||||||||||||||||||||||||||||
1.1 | Direct premium written | Pt 2, Ln 1.1 | ||||||||||||||||||||||||||||||||||||||||||||
1.2 | Unearned premium prior year | Pt 2, Ln 1.2 | ||||||||||||||||||||||||||||||||||||||||||||
1.3 | Unearned premium MLR Reporting year | Pt 2, Ln 1.3 | ||||||||||||||||||||||||||||||||||||||||||||
1.4 | Experience rating refunds (rate credits) paid | |||||||||||||||||||||||||||||||||||||||||||||
1.4a Experience rating refunds, with all incurred dates, paid in the MLR reporting year | Pt 2, Ln 1.5 | |||||||||||||||||||||||||||||||||||||||||||||
1.4b Experience rating refunds associated with premium earned only in the reporting year and paid through 3/31 of the following year | ||||||||||||||||||||||||||||||||||||||||||||||
1.5 | Reserve for experience rating refunds (rate credits) MLR Reporting year | Pt 2, Ln 1.6 | ||||||||||||||||||||||||||||||||||||||||||||
1.6 | Reserve for experience rating refunds (rate credits) prior year | Pt 2, Ln 1.7 | ||||||||||||||||||||||||||||||||||||||||||||
1.7 | Premium balances written off | Pt 2, Ln 1.9 | ||||||||||||||||||||||||||||||||||||||||||||
1.8 | Group conversion charges | Pt 2, Ln 1.10 | ||||||||||||||||||||||||||||||||||||||||||||
1.9 | Premium ceded under 100% reinsurance (informational only; excluded from Line 1.1) | |||||||||||||||||||||||||||||||||||||||||||||
1.10 | Premium assumed under 100% reinsurance (informational only; already included in Line 1.1) | |||||||||||||||||||||||||||||||||||||||||||||
2. | Claims: | |||||||||||||||||||||||||||||||||||||||||||||
2.1 | Claims Paid | |||||||||||||||||||||||||||||||||||||||||||||
2.1a Claims paid during the MLR reporting year regardless of incurred date | Pt 2, Ln 2.1 | |||||||||||||||||||||||||||||||||||||||||||||
2.1b Claims incurred only during the MLR reporting year, paid through 3/31 of the following year | ||||||||||||||||||||||||||||||||||||||||||||||
2.2 | Direct claim liability | |||||||||||||||||||||||||||||||||||||||||||||
2.2a Liability as of 12/31 of MLR reporting year for all claims regardless of incurred date | Pt 2, Ln 2.2 | |||||||||||||||||||||||||||||||||||||||||||||
2.2b Liability for claims incurred only during the MLR reporting year, calculated as of 3/31 of the following year | ||||||||||||||||||||||||||||||||||||||||||||||
2.3 | Direct claim liability prior year | Pt 2, Ln 2.3 | ||||||||||||||||||||||||||||||||||||||||||||
2.4 | Direct claim reserves | |||||||||||||||||||||||||||||||||||||||||||||
2.4a Reserves as of 12/31 of MLR reporting year for all claims regardless of incurred date | Pt 2, Ln 2.4 | |||||||||||||||||||||||||||||||||||||||||||||
2.4b Reserves for claims incurred only during the MLR reporting year, calculated as of 3/31 of the following year | ||||||||||||||||||||||||||||||||||||||||||||||
2.5 | Direct claim reserves prior year | Pt 2, Ln 2.5 | ||||||||||||||||||||||||||||||||||||||||||||
2.6 | Direct contract reserves | |||||||||||||||||||||||||||||||||||||||||||||
2.6a Direct contract reserves 12/31 column | Pt 2, Ln 2.6 | |||||||||||||||||||||||||||||||||||||||||||||
2.6b Direct contract reserves 3/31, dual contract, deferred columns | ||||||||||||||||||||||||||||||||||||||||||||||
2.7 | Direct contract reserves prior year | Pt 2, Ln 2.7 | ||||||||||||||||||||||||||||||||||||||||||||
2.8 | Experience rating refunds (rate credits) paid | |||||||||||||||||||||||||||||||||||||||||||||
2.8a Experience rating refunds, with all incurred dates, paid in the MLR reporting year | Pt 2, Ln 2.8 | |||||||||||||||||||||||||||||||||||||||||||||
2.8b Experience rating refunds associated with premium earned only in the reporting year and paid through 3/31 of the following year | ||||||||||||||||||||||||||||||||||||||||||||||
2.9 | Reserve for experience rating refunds (rate credits) | |||||||||||||||||||||||||||||||||||||||||||||
2.9a Reserved in MLR reporting year regardless of incurred date | Pt 2, Ln 2.9 | |||||||||||||||||||||||||||||||||||||||||||||
2.9b Reserves specific to the MLR reporting year through 3/31 of the following year | ||||||||||||||||||||||||||||||||||||||||||||||
2.10 | Reserve for experience rating refunds (rate credits) prior year | Pt 2, Ln 2.10 | ||||||||||||||||||||||||||||||||||||||||||||
2.11 | Incurred medical incentive pool and bonuses | |||||||||||||||||||||||||||||||||||||||||||||
2.11a Paid medical incentive pools and bonuses MLR Reporting year | Pt 2, Ln 2.11a | |||||||||||||||||||||||||||||||||||||||||||||
2.11b Accrued medical incentive pools and bonuses MLR Reporting year | Pt 2, Ln 2.11b | |||||||||||||||||||||||||||||||||||||||||||||
2.11c Accrued medical incentive pools and bonuses prior year | Pt 2, Ln 2.11c | |||||||||||||||||||||||||||||||||||||||||||||
2.12 | Net healthcare receivables | |||||||||||||||||||||||||||||||||||||||||||||
2.12a Healthcare receivables MLR Reporting year | Pt 2, Ln 2.12a | |||||||||||||||||||||||||||||||||||||||||||||
2.12b Healthcare receivables prior year | Pt 2, Ln 2.12b | |||||||||||||||||||||||||||||||||||||||||||||
2.13 | Contingent benefit and lawsuit reserves | |||||||||||||||||||||||||||||||||||||||||||||
2.14 | Group conversion charges | Pt 2, Ln 2.13 | ||||||||||||||||||||||||||||||||||||||||||||
2.15 | Blended rate adjustment | Pt 2, Ln 2.14 | ||||||||||||||||||||||||||||||||||||||||||||
2.16 | Total incurred claims | Pt 2, Ln 2.15 | ||||||||||||||||||||||||||||||||||||||||||||
2.17 | Allowable fraud reduction expense (the smaller of Lines 2.17a or 2.17b) | Pt 1, Ln 4 | ||||||||||||||||||||||||||||||||||||||||||||
2.17a Total fraud reduction expense | Pt 3, Col 7, Ln 1.11/ 2.11/3.11/5.11/6.11 | |||||||||||||||||||||||||||||||||||||||||||||
2.17b Total fraud recoveries that reduced paid claims in Line 2.1 | Pt 2, Ln 3 | |||||||||||||||||||||||||||||||||||||||||||||
Cell Keys: | ||||||||||||||||||||||||||||||||||||||||||||||
Blank cells require input from issuer | ||||||||||||||||||||||||||||||||||||||||||||||
Grey cells require no data input – input will result in an upload failure | ||||||||||||||||||||||||||||||||||||||||||||||
Pink cells require no data input - locked down | ||||||||||||||||||||||||||||||||||||||||||||||
Blue cells require a calculation by the issuer |
Department of Health and Human Services | Federal EIN : | DBA / Marketing Name: | Federal Tax Exempt | |||||||
2013 Medical Loss Ratio Reporting Form | ||||||||||
Part 3 - Expense Allocation | A.M. Best Number: | Issuer ID: | Merge Markets - Ind/SmGrp | |||||||
Group Affiliation: | NAIC Group Code: | Business in the State of: | Not-For-Profit | |||||||
Company Name: | NAIC Company Code: | Domiciliary State: | MLR Reporting Year: | |||||||
2013 | ||||||||||
Description of Expense Element (by Type) | NEW | Detailed Description of Expense Allocation Methods | ||||||||
1 | 2 | 3 | ||||||||
1. Incurred Claims | ||||||||||
2. Federal and State Taxes and Licensing or Regulatory Fees | ||||||||||
2.a Federal taxes and assessments | ||||||||||
2.b State insurance, premium and other taxes | ||||||||||
2.c Community benefit expenditures | ||||||||||
2.d Regulatory authority licenses and fees | ||||||||||
3. Quality Improvement Expenses | ||||||||||
3.a Improve health outcomes | ||||||||||
3.b Activities to prevent hospital readmission | ||||||||||
3.c Improve patient safety and reduce medical errors | ||||||||||
3.d Wellness and health promotion activities | ||||||||||
3.e Health Information Technology expenses related to healthcare quality | ||||||||||
3.f Allowable ICD-10 Expenses | ||||||||||
4. Non-Claims costs | ||||||||||
4.a Cost containment expenses not included in quality improvement expenses | ||||||||||
4.b All other claims adjustment expenses | ||||||||||
4.c Direct sales salaries and benefits | ||||||||||
4.d Agents and brokers fees and commissions | ||||||||||
4.e Other taxes | ||||||||||
4.f Other general and administrative expenses | ||||||||||
4.g Community benefit expenditures | ||||||||||
4.h ICD-10 implementation expenses | ||||||||||
Cell Keys: | ||||||||||
Blank cells require input from issuer | ||||||||||
Grey cells require no data input – input will result in an upload failure | ||||||||||
Pink cells require no data input - locked down | ||||||||||
Blue cells require a calculation by the issuer |
Department of Health and Human Services | Federal EIN : | DBA / Marketing Name: | Federal Tax Exempt | |||||||||||||||||||||||||||||||||||
2013 Medical Loss Ratio Reporting Form | ||||||||||||||||||||||||||||||||||||||
Part 4 - MLR and Rebate Calculation | A.M. Best Number: | Issuer ID: | Merge Markets - Ind/SmGrp | |||||||||||||||||||||||||||||||||||
Group Affiliation: | NAIC Group Code: | Business in the State of: | Not-For-Profit | |||||||||||||||||||||||||||||||||||
Company Name: | NAIC Company Code: | Domiciliary State: | MLR Reporting Year: | |||||||||||||||||||||||||||||||||||
2013 | ||||||||||||||||||||||||||||||||||||||
Health Insurance Coverage | Mini-Med Plans | Expatriate Plans | Student Health Plans | |||||||||||||||||||||||||||||||||||
Individual | Small Group | Large Group | Individual | Small Group | Large Group | Small Group | Large Group | Individual | ||||||||||||||||||||||||||||||
Part 4 NOTE: REFER TO MLR INSTRUCTIONS, FORMULAS RESOURCE AND TABLES RESOURCE FOR IMPORTANT INFORMATION ABOUT COMPLETING EACH COLUMN AND ROW. |
PY2 | PY1 | CY | Total | PY2 | PY1 | CY | Total | PY2 | PY1 | CY | Total | PY2 | PY1 | CY | Total | PY2 | PY1 | CY | Total | PY2 | PY1 | CY | Total | PY2 | PY1 | CY | Total | PY2 | PY1 | CY | Total | PY2 | PY1 | CY | Total | ||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | |||
1. | Medical Loss Ratio Numerator | |||||||||||||||||||||||||||||||||||||
1.1 | Adjusted incurred claims as reported on MLR Form for prior year(s) | |||||||||||||||||||||||||||||||||||||
1.2 | Adjusted incurred claims as of 3/31 of the year following the MLR reporting year | |||||||||||||||||||||||||||||||||||||
1.3 | Improving Health Care Quality Expenses | |||||||||||||||||||||||||||||||||||||
1.4 | MLR rebates paid based on 2011 or 2012 experience | |||||||||||||||||||||||||||||||||||||
1.5 | MLR numerator | |||||||||||||||||||||||||||||||||||||
1.6 | MLR numerator Mini-Med and Student Health (using adjustment factor). |
|||||||||||||||||||||||||||||||||||||
2. | Medical Loss Ratio Denominator | |||||||||||||||||||||||||||||||||||||
2.1 | Premium earned including Federal and State high risk programs | |||||||||||||||||||||||||||||||||||||
2.2 | Federal and State taxes and licensing or regulatory fees | |||||||||||||||||||||||||||||||||||||
2.3 | MLR Denominator (Line 2.1 - Line 2.2) | |||||||||||||||||||||||||||||||||||||
3. | Credibility Adjustment | |||||||||||||||||||||||||||||||||||||
3.1 | Life-years | |||||||||||||||||||||||||||||||||||||
3.2 | Base credibility factor | |||||||||||||||||||||||||||||||||||||
3.3 | Average deductible | |||||||||||||||||||||||||||||||||||||
3.4 | Deductible factor | |||||||||||||||||||||||||||||||||||||
3.5 | Credibility adjustment (Lines 3.2 x 3.4 (do not round)) | |||||||||||||||||||||||||||||||||||||
4. | MLR Calculation (for issuers with at least 1,000 life years in the Total column of Line 3.1) | |||||||||||||||||||||||||||||||||||||
4.1 | Preliminary MLR | |||||||||||||||||||||||||||||||||||||
4.1a Preliminary MLR (Lines 1.5 / 2.3) | ||||||||||||||||||||||||||||||||||||||
4.1b Preliminary MLR: Mini-Med and Student Health (Lines 1.6 / 2.3) |
||||||||||||||||||||||||||||||||||||||
4.2 | Credibility adjustment (Line 3.5, if applicable) | |||||||||||||||||||||||||||||||||||||
4.3 | Credibility-adjusted MLR (Lines 4.1a or 4.1b + 4.2) | |||||||||||||||||||||||||||||||||||||
5. | Rebate Calculation | |||||||||||||||||||||||||||||||||||||
5.1 | MLR standard | |||||||||||||||||||||||||||||||||||||
5.2 | Credibility-adjusted MLR (Line 4.3) | |||||||||||||||||||||||||||||||||||||
5.3 | Adjusted earned premium (Line 2.1 - 2.2 CY) | |||||||||||||||||||||||||||||||||||||
5.4 | Rebate amount if credibility-adjusted MLR is less than MLR standard (Lines (5.1 - 5.2) X 5.3) | |||||||||||||||||||||||||||||||||||||
6. | Optional temporary adjustments | |||||||||||||||||||||||||||||||||||||
6.1 | ACA assessments on non-calendar year policies (2013 only) | |||||||||||||||||||||||||||||||||||||
6.1a Deferred portion of 2013 premium collected for 2014 ACA assessments or fees. |
||||||||||||||||||||||||||||||||||||||
6.1b Total Federal and State taxes associated with the deferred premium on Line 6.1a. |
||||||||||||||||||||||||||||||||||||||
6.2 | Reserved for future use | |||||||||||||||||||||||||||||||||||||
6.2a Reserved for future use | ||||||||||||||||||||||||||||||||||||||
6.2b Reserved for future use | ||||||||||||||||||||||||||||||||||||||
6.2c Reserved for future use | ||||||||||||||||||||||||||||||||||||||
6.2d Reserved for future use | ||||||||||||||||||||||||||||||||||||||
6.2e Reserved for future use | ||||||||||||||||||||||||||||||||||||||
6.2f Reserved for future use | ||||||||||||||||||||||||||||||||||||||
Blank cells require input from issuer | ||||||||||||||||||||||||||||||||||||||
Grey cells require no data input – input will result in an upload failure | ||||||||||||||||||||||||||||||||||||||
Pink cells require no data input - locked down | ||||||||||||||||||||||||||||||||||||||
Blue cells require a calculation by the issuer |
Department of Health and Human Services | Federal EIN : | DBA / Marketing Name: | Federal Tax Exempt | ||||||||
2013 Medical Loss Ratio Reporting Form | |||||||||||
Part 5 - Rebate Disbursement | A.M. Best Number: | Issuer ID: | Merge Markets - Ind/SmGrp | ||||||||
Group Affiliation: | NAIC Group Code: | Business in the State of: | Not-For-Profit | ||||||||
Company Name: | NAIC Company Code: | Domiciliary State: | MLR Reporting Year: | ||||||||
2013 | |||||||||||
Health Insurance Coverage | Mini-Med Plans | Expatriate Plans | Student Health Plans | ||||||||
Individual | Small Group | Large Group | Individual | Small Group | Large Group | Small Group | Large Group | Individual | |||
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |||
1. | Number of policies / certificates (from Part 1, Line 7.1) | ||||||||||
2. | Number of policyholders/subscribers owed rebates | ||||||||||
2.a Number of group policyholders being paid a rebate | |||||||||||
2.b Number of subscribers being paid a rebate | |||||||||||
2.c Number of group policyholders whose rebate is de minimis | |||||||||||
2.d Number of subscribers whose rebate is de minimis | |||||||||||
3. | Total amount of rebates | ||||||||||
3.a Total amount of rebates (from Part 4, Line 5.4) | |||||||||||
3.b Amount of de minimis rebates | |||||||||||
3.c Amount of rebates being paid by premium credit | |||||||||||
3.d Amount of rebates being paid by lump-sum reimbursement | |||||||||||
4. | Prior MLR year rebates | ||||||||||
4.a Total amount of rebates paid for the previous MLR reporting year | |||||||||||
4.b Total amount of rebates still owed for the previous MLR reporting year | |||||||||||
4.c Percentage of notices sent timely to individual policy subscribers or group policyholders owed a rebate | |||||||||||
4.d Percentage of notices sent timely to subscribers of group policies owed a rebate | |||||||||||
4.e Percentage of rebates paid timely to individual policy subscribers or group policyholders owed a rebate | |||||||||||
4.f Percentage of rebates paid timely to subscribers of group policies owed a rebate | |||||||||||
4.g Amount of unclaimed rebates from prior MLR reporting years | |||||||||||
4.h Describe methods used to locate policyholders/subscribers for prior MLR reporting year's unclaimed rebates: | |||||||||||
4.i Describe disbursement of prior MLR reporting year's unclaimed rebates: | |||||||||||
Cell Keys: | |||||||||||
Blank cells require input from issuer | |||||||||||
Grey cells require no data input – input will result in an upload failure | |||||||||||
Pink cells require no data input - locked down | |||||||||||
Blue cells require a calculation by the issuer |
Department of Health and Human Services | Federal EIN : | DBA / Marketing Name: | Federal Tax Exempt | ||||||
2013 Medical Loss Ratio Reporting Form | |||||||||
Part 6 - Additional Responses | A.M. Best Number: | Issuer ID: | Merge Markets - Ind/SmGrp | ||||||
Group Affiliation: | NAIC Group Code: | Business in the State of: | Not-For-Profit | ||||||
Company Name: | NAIC Company Code: | Domiciliary State: | MLR Reporting Year: | ||||||
2013 | |||||||||
Tax Rate | |||||||||
1. If an amount is reported in Part 1 Line 3.2c, Community benefit expenditures, provide the state premium tax rate used to determine the reported amount: | |||||||||
2. If the issuer reported amounts in Part 2 Line 2.15 Blended rate adjustment provide the affiliate(s) name(s) with whom blended rate adjustments were made. | |||||||||
Name of Affiliate | |||||||||
3. If the issuer reported amounts in the Dual Contract 3/31 Columns provide the affiliate(s) name(s) with whom experience is being reported. | |||||||||
Name of Affiliate | |||||||||
4. If the issuer entered into any 100% assumptive reinsurance agreements with a novation during the MLR reporting year, provide the name(s) of the entity(ies) with whom the agreement was (were) made and the effective date of the novation. | |||||||||
Name of Entity with whom Agreement was made | Effective Date of Novation | ||||||||
5. If the Issuer novated any business in the MLR reporting year effective during the reporting year provide the name of the entity to whom the business was sold or transferred and the date of the sale or transfer. | |||||||||
Name of Entity to whom business was sold or transferred | Effective Date of sale or transfer | ||||||||
6. If the issuer has any 100% indemnity reinsurance and administrative agreements effective prior to March 23, 2010, for which the assuming entity is responsible for 100% of the ceding entity's financial risk and takes on all of the administration of the block, report the name(s) of the entity(ies) that is (are) reporting the experience related to such business. | |||||||||
Cell Keys: | |||||||||
Blank cells require input from issuer | |||||||||
Grey cells require no data input – input will result in an upload failure | |||||||||
Pink cells require no data input - locked down | |||||||||
Blue cells require a calculation by the issuer |
Department of Health and Human Services | |||||||||||||
2013 Medical Loss Ratio Reporting Form | Federal Tax Exempt | ||||||||||||
Group Affiliation: | Federal EIN : | Issuer ID: | Merge Markets - Ind/SmGrp | ||||||||||
Company Name: | A.M. Best Number: | Business in the State of: | Not-for-Profit | ||||||||||
DBA/Marketing Name: | NAIC Group Code: | Domiciliary State: | MLR Reporting Year: | ||||||||||
2013 | |||||||||||||
Address: | NAIC Company Code: | ||||||||||||
Attestation Statement | |||||||||||||
The officers of this reporting issuer being duly sworn, each attest that he/she is the described officer of the reporting issuer, and that this MLR Reporting Form, the Company/Issuer Associations, and any supplemental submission that the issuer includes are full and true statements of all the elements included therein for the MLR reporting year stated above, and that the MLR Reporting Form has been completed in accordance with the Department of Health and Human Services’ reporting instructions, according to the best of his/her information, knowledge and belief. Furthermore, the scope of this attestation by the described officer includes any related electronic filings and postings for the MLR reporting year stated above and which are required by Department of Health and Human Services under section 2718 of the Public Health Service Act and implementing regulation. | |||||||||||||
____________________________ | |||||||||||||
Chief Executive Officer/President | |||||||||||||
____________________________ | |||||||||||||
Chief Financial Officer |
Table 1 | Table 3 | Table 4 | Table 5 | ||||
Base Credibility Adjustment Factors | State and Territory Names | Reporting Years | Yes/No | ||||
Life Years | Base credibility factor | Alaska | 2011 | Yes | |||
- | 0.0% | Alabama | 2012 | No | |||
1,000 | 8.3% | Arkansas | 2013 | ||||
2,500 | 5.2% | American Samoa | 2014 | ||||
5,000 | 3.7% | Arizona | 2015 | ||||
10,000 | 2.6% | California | 2016 | ||||
25,000 | 1.6% | Canada | 2017 | ||||
50,000 | 1.2% | Colorado | 2018 | ||||
75,000 | 0.0% | Connecticut | 2019 | ||||
District of Columbia | 2020 | ||||||
Delaware | 2021 | ||||||
Table 2 | Florida | 2022 | |||||
Deductible Factors | Georgia | 2023 | |||||
Average Health Plan Deductible | Deductible factor | Guam | 2024 | ||||
$0 | 1.000 | Hawaii | 2025 | ||||
$2,500 | 1.164 | Iowa | 2026 | ||||
$5,000 | 1.402 | Idaho | 2027 | ||||
$10,000 | 1.736 | Illinois | 2028 | ||||
Indiana | 2029 | ||||||
Kansas | 2030 | ||||||
Kentucky | 2031 | ||||||
Louisiana | 2032 | ||||||
Massachusetts | 2033 | ||||||
Maryland | 2034 | ||||||
Maine | 2035 | ||||||
Michigan | 2036 | ||||||
Minnesota | 2037 | ||||||
Missouri | 2038 | ||||||
MP | 2039 | ||||||
Mississippi | 2040 | ||||||
Montana | 2041 | ||||||
North Carolina | 2042 | ||||||
North Dakota | 2043 | ||||||
Nebraska | 2044 | ||||||
New Hampshire | 2045 | ||||||
New Jersey | 2046 | ||||||
New Mexico | 2047 | ||||||
Nevada | 2048 | ||||||
New York | 2049 | ||||||
Ohio | 2050 | ||||||
Oklahoma | 2051 | ||||||
Oregon | 2052 | ||||||
Other Territories | 2053 | ||||||
Pennsylvania | 2054 | ||||||
Puerto Rico | 2055 | ||||||
Rhode Island | 2056 | ||||||
South Carolina | 2057 | ||||||
South Dakota | 2058 | ||||||
Tennessee | 2059 | ||||||
Texas | 2060 | ||||||
Utah | |||||||
Virginia | |||||||
Virgin Islands | |||||||
Vermont | |||||||
Washington | |||||||
Wisconsin | |||||||
West Virginia | |||||||
Wyoming | |||||||
Grand Total |
File Type | application/vnd.openxmlformats-officedocument.spreadsheetml.sheet |
File Modified | 0000-00-00 |
File Created | 0000-00-00 |